Form 4/A for ANVS Annovis Bio, Inc.
Accepted 2025-11-25 00:00:00 ET · period of report 2025-11-24 · accession 0001104659-25-116084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MA | 2025-11-25 | 2025-11-24 | ANVS | Hoffman Michael B | Dir | P - Purchase | $4.08 | +39.2K | 2.50M | +2% | +$159.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-24 | P | A | 1,489 | $4.13 | 2,492,028 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-24 | P | A | 28,096 | $4.15 | 2,529,739 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-24 | P | A | 415 | $4.14 | 2,501,643 | D | — | — | |
| 4 | Common | Common Stock | 2025-11-24 | P | A | 9,200 | $3.85 | 2,501,228 | D | — | — |